Skip to main content
. 2022 Apr 9;40(8):800–813. doi: 10.1007/s11604-022-01270-5

Table 1.

Demographic and clinical data, quantitative radiological indexes, and qualitative CT severity scores for early and late treatment groups

Early treatment (n = 18) Late treatment (n = 14) p value
Age (years) (Mean ± standard deviation) 51 ± 19 52 ± 12 0.43
Gender Male: female 10:8 9:5 0.32
Height (cm) (Mean ± standard deviation) 163.4 ± 10.5 165.1 ± 9.2 0.59
Body weight (Kg) (Mean ± standard deviation) 62.2 ± 16.1 67.7 ± 10.3 0.17
Clinical symptoms Number (%) 18 (100) 12 (85.7) 0.07
Fever Number (%) 10 (55.6) 8 (57.1) 0.93
Time between onset of clinical symptoms and CT examination (days) (Mean ± standard deviation) 5.8 ± 3.3 5.9 ± 3.7 0.88

Quantitative indexes

(%: mean ± standard deviation)

Normal lung 86.6 ± 5.6 86.9 ± 7.9 0.56
GGO 7.1 ± 4.7 7.1 ± 4.8 0.99
Reticulation or crazy paving 3.7 ± 3.8 4.2 ± 4.7 0.81
Emphysema 0.7 ± 1.7 0.5 ± 1.1 0.59
Nodular lesion 0.0 ± 0.0 0.0 ± 0.0 0.27
Consolidation 1.8 ± 2.3 1.2 ± 1.8 0.47
Honeycombing 0.1 ± 0.1 0.1 ± 0.1 0.66
CT disease severity score (Mean ± standard deviation) 5.6 ± 4.7 7.1 ± 3.9 0.24

GGO ground-glass opacity